- Home
- CRBU vs RCKY Comparison
CRBU vs RCKY Comparison
Compare CRBU & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- RCKY
- Stock Information
- Founded
- CRBU 2011
- RCKY 1932
- Country
- CRBU United States
- RCKY United States
- Employees
- CRBU N/A
- RCKY N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- RCKY Shoe Manufacturing
- Sector
- CRBU Health Care
- RCKY Consumer Discretionary
- Exchange
- CRBU Nasdaq
- RCKY Nasdaq
- Market Cap
- CRBU 188.8M
- RCKY 196.3M
- IPO Year
- CRBU 2021
- RCKY 1993
- Fundamental
- Price
- CRBU $1.93
- RCKY $30.92
- Analyst Decision
- CRBU Strong Buy
- RCKY Buy
- Analyst Count
- CRBU 3
- RCKY 1
- Target Price
- CRBU $6.67
- RCKY $40.00
- AVG Volume (30 Days)
- CRBU 1.0M
- RCKY 81.7K
- Earning Date
- CRBU 08-12-2025
- RCKY 07-29-2025
- Dividend Yield
- CRBU N/A
- RCKY 2.03%
- EPS Growth
- CRBU N/A
- RCKY 24.23
- EPS
- CRBU N/A
- RCKY 2.48
- Revenue
- CRBU $9,121,000.00
- RCKY $462,328,000.00
- Revenue This Year
- CRBU $9.23
- RCKY $7.02
- Revenue Next Year
- CRBU N/A
- RCKY $3.96
- P/E Ratio
- CRBU N/A
- RCKY $12.31
- Revenue Growth
- CRBU N/A
- RCKY N/A
- 52 Week Low
- CRBU $0.66
- RCKY $11.93
- 52 Week High
- CRBU $3.00
- RCKY $33.04
- Technical
- Relative Strength Index (RSI)
- CRBU 56.96
- RCKY 71.42
- Support Level
- CRBU $1.80
- RCKY $25.76
- Resistance Level
- CRBU $2.16
- RCKY $31.30
- Average True Range (ATR)
- CRBU 0.14
- RCKY 1.04
- MACD
- CRBU 0.00
- RCKY 0.33
- Stochastic Oscillator
- CRBU 73.28
- RCKY 88.81
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.